OPKO Health Inc (OPK)

8.97
0.04 0.45
NASDAQ : Health Care
Prev Close 8.93
Open 8.98
Day Low/High 8.82 / 8.99
52 Wk Low/High 7.12 / 17.51
Volume 1.08M
Avg Volume 4.56M
Exchange NASDAQ
Shares Outstanding 557.53M
Market Cap 5.10B
EPS -0.10
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Dow, S&P 500 and Nasdaq Close Out 2016 With Strong Gains

Dow, S&P 500 and Nasdaq Close Out 2016 With Strong Gains

Stocks closed lower on the final trading day of 2016, but all three indices close the year with gains.

Closing Bell: Stocks Fall for the Day, but Gain in 2016; Apple, Opko Health Shares Drop

Closing Bell: Stocks Fall for the Day, but Gain in 2016; Apple, Opko Health Shares Drop

Stocks close out the day slightly down, but post gains for 2016.

Dow, S&P 500 and Nasdaq Fall as Technology Sector Pulls Markets Down

Dow, S&P 500 and Nasdaq Fall as Technology Sector Pulls Markets Down

Stocks moved mostly lower on the final day of trading of 2016, but all three indices are poised to close 2016 with gains.

Stocks Mostly Lower on Last Trading Day of 2016

Stocks Mostly Lower on Last Trading Day of 2016

Stocks were falling below the baseline as 2016 comes to a close.

Analysts' Actions -- Ciena, Salesforce, Square, Western Digital and More

Analysts' Actions -- Ciena, Salesforce, Square, Western Digital and More

Here are Tuesday's top research calls, including an upgrade for Western Digital and new coverage for Ciena, Salesforce and Square.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: CTRL, GLAD, MERC, MTRX, OPK, PNNT, RLJ, RMP, SBCP, TBBK Downgrades: MJCO Initiations: CSRA Read on to get TheStreet Quant Ratings' detailed report:

'Mad Money' Lightning Round: Kohlberg Kravis Roberts, Opko Health Are Worth It

'Mad Money' Lightning Round: Kohlberg Kravis Roberts, Opko Health Are Worth It

Jim Cramer says he's still 'a believer' in KKR and Opko.

Jim Cramer's 'Mad Money' Recap: Mild Pullback Means We Are Getting Back to Normal

Jim Cramer's 'Mad Money' Recap: Mild Pullback Means We Are Getting Back to Normal

Stocks kept rallying right through and after this rate hike, says Jim Cramer.

Opko Health Has 3 Very Attractive Charts

Opko Health Has 3 Very Attractive Charts

But it now or buy it when it's higher.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AER, AIMC, ALLY, BKU, PH, VSH Downgrades: CRAY, HMSY, OPK, SOHO, SONS, TRNC, TSRI, UTSI Initiations: CTMX, DERM Read on to get TheStreet Quant Ratings' detailed report:

Opko Healthcare's Phillip Frost Is a Major Microcap Investor

Opko Healthcare's Phillip Frost Is a Major Microcap Investor

Opko Healthcare's CEO is chairman of an investment bank and number 134 on the Forbes 400 richest people in the world.

'Mad Money' Lightning Round: I'm Faithful to Opko Health's CEO

'Mad Money' Lightning Round: I'm Faithful to Opko Health's CEO

Cramer is avoiding TPC Composites and is lukewarm on Kinder Morgan.

Jim Cramer's 'Mad Money' Recap: Don't Play the Short-Term Market Game

Jim Cramer's 'Mad Money' Recap: Don't Play the Short-Term Market Game

Consistency and discipline are two values this market has sorely lacked in 2016, Cramer says.

OPKO Health Appoints Dr. Benjamin Solomon As Managing Director Of GeneDx

OPKO Health Appoints Dr. Benjamin Solomon As Managing Director Of GeneDx

OPKO Health, Inc. (NASDAQ:OPK), announces the appointment of Benjamin D.

OPKO Health To Present At The Ladenburg Thalmann 2016 Healthcare Conference

OPKO Health To Present At The Ladenburg Thalmann 2016 Healthcare Conference

OPKO Health, Inc. (NASDAQ:OPK) today announced that senior management will present at the Ladenburg Thalmann 2016 Healthcare Conference on September 27th, 2016 at 10:30 AM (ET).

Look for Test of Key Index Again

Besides testing the S&P 500's 2100 level, we're also likely to see volume pick up as we head toward Friday's triple-witching expiration finale.

OPKO Health Appoints Jane Pine Wood As Chief Legal And Compliance Officer Of BioReference Laboratories

OPKO Health Appoints Jane Pine Wood As Chief Legal And Compliance Officer Of BioReference Laboratories

OPKO Health, Inc. (Nasdaq: OPK) announces the appointment of Jane Pine Wood, Esq.

OPKO To Present Long-acting Human Growth Hormone (hGH-CTP) Phase 2 Pediatric Growth Hormone Deficiency Data At The 55th Annual Meeting Of The European Society For Paediatric Endocrinology

OPKO To Present Long-acting Human Growth Hormone (hGH-CTP) Phase 2 Pediatric Growth Hormone Deficiency Data At The 55th Annual Meeting Of The European Society For Paediatric Endocrinology

OPKO Health, Inc. (NASDAQ:OPK) will present abstracts at the 55 th Annual Meeting of the European Society for Paediatric Endocrinology (ESPE) to be held in Paris, France on September 10-12, 2016.